Bruker SG&A Expenses 2012-2026 | BRKR
Bruker annual/quarterly sg&a expenses history and growth rate from 2012 to 2026. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Bruker sg&a expenses for the quarter ending March 31, 2026 were $0.242B, a 7.41% increase year-over-year.
- Bruker sg&a expenses for the twelve months ending March 31, 2026 were $0.963B, a 4.25% increase year-over-year.
- Bruker annual sg&a expenses for 2025 were $0.947B, a 5.9% increase from 2024.
- Bruker annual sg&a expenses for 2024 were $0.894B, a 22.54% increase from 2023.
- Bruker annual sg&a expenses for 2023 were $0.729B, a 20.09% increase from 2022.
|
Bruker Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025 | $947 |
| 2024 | $894 |
| 2023 | $729 |
| 2022 | $607 |
| 2021 | $561 |
| 2020 | $469 |
| 2019 | $500 |
| 2018 | $445 |
| 2017 | $415 |
| 2016 | $390 |
| 2015 | $392 |
| 2014 | $451 |
| 2013 | $438 |
| 2012 | $440 |
| 2011 | $407 |
|
Bruker Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2026-03-31 | $242 |
| 2025-12-31 | $247 |
| 2025-09-30 | $243 |
| 2025-06-30 | $231 |
| 2025-03-31 | $225 |
| 2024-12-31 | $247 |
| 2024-09-30 | $230 |
| 2024-06-30 | $221 |
| 2024-03-31 | $195 |
| 2023-12-31 | $211 |
| 2023-09-30 | $178 |
| 2023-06-30 | $178 |
| 2023-03-31 | $163 |
| 2022-12-31 | $165 |
| 2022-09-30 | $145 |
| 2022-06-30 | $152 |
| 2022-03-31 | $146 |
| 2021-12-31 | $153 |
| 2021-09-30 | $141 |
| 2021-06-30 | $135 |
| 2021-03-31 | $132 |
| 2020-12-31 | $130 |
| 2020-09-30 | $115 |
| 2020-06-30 | $102 |
| 2020-03-31 | $121 |
| 2019-12-31 | $130 |
| 2019-09-30 | $125 |
| 2019-06-30 | $125 |
| 2019-03-31 | $120 |
| 2018-12-31 | $117 |
| 2018-09-30 | $107 |
| 2018-06-30 | $111 |
| 2018-03-31 | $110 |
| 2017-12-31 | $112 |
| 2017-09-30 | $103 |
| 2017-06-30 | $103 |
| 2017-03-31 | $98 |
| 2016-12-31 | $99 |
| 2016-09-30 | $97 |
| 2016-06-30 | $101 |
| 2016-03-31 | $93 |
| 2015-12-31 | $103 |
| 2015-09-30 | $96 |
| 2015-06-30 | $99 |
| 2015-03-31 | $95 |
| 2014-12-31 | $119 |
| 2014-09-30 | $108 |
| 2014-06-30 | $115 |
| 2014-03-31 | $110 |
| 2013-12-31 | $118 |
| 2013-09-30 | $106 |
| 2013-06-30 | $107 |
| 2013-03-31 | $107 |
| 2012-12-31 | $123 |
| 2012-09-30 | $102 |
| 2012-06-30 | $111 |
| 2012-03-31 | $104 |
| 2011-12-31 | $117 |
| 2011-09-30 | $102 |
| 2011-06-30 | $98 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |